Dental Membrane and Bone Graft Substitutes Market: Collagen Becoming the Preferred Material of Choice
There has been a rise in the incidence of oral problems across all age groups, leading to a spike in the demand for dental surgeries, globally. This has led to newer and better materials being discovered for use as dental membrane and bone graft substitutes. Of these substitutes, human cell sources and other species have conventionally been the most popular bone graft substitutes, and collectively held a share of around three-fourth of the global market in 2018. Despite the popularity of other materials catching up, these segments are expected to remain the most significant in the global dental membrane and bone graft substitutes market over the period of 2019 to 2027.
However, collagen, a structural protein that is generally found in human bones, is being increasingly used as a biocompatible dental membrane and bone graft substitute, causing its popularity to spike in recent years, as it promotes would healing and improves clinical outcomes. As such, the collagen segment was valued at ~US$ 40 Mn in 2018, with a relatively small share of one-fifth of the global dental membrane and bone graft substitutes market, but is expected to expand the fastest at a CAGR of 8.5% over the forecast period.
To know the scope of our report Get a Sample on Dental Membrane and Bone Graft Substitutes Market
Resorbable Dental Membranes Gaining Popularity in Recent Years
Dental membranes, which prevent gums from growing into the bone cavity, accounted for ~40% of the total share of the dental membrane and bone graft substitutes market, by product type, in 2018. Of this, resorbable dental membranes accounted for a lion’s share of ~90% in 2018, equivalent to ~ US$ 213 Mn, and its share is expected to double by the end of 2027. This popularity can be attributed to the numerous benefits that they offer, including cost-effectiveness, decrease in patient morbidity, and elimination of the need for membrane removal, thereby shortening the healing process. This is particularly significant due to the surge in the demand for collagen resorbable dental membranes that promote oral tissue regeneration.
Get a glimpse of the in-depth analysis through our Report Brochure
High Costs of Dental Procedures - Market Restraint
Even as the incidence of dental issues increases around the world, and the demand for procedures also surges, costs associated with these advanced procedures and treatments are also rising. These rising costs can be attributed to the rising costs of materials used - including implants, membrane and graft materials and substitutes, and customization - which is offered as a norm for every patient. Also contributing to this is the length of dental treatments, which often determines the cost of the procedure. These factors have had a restraining effect on the global dental membrane and bone graft substitutes market, and are expected to continue to do the same during the forecast period, preventing the market from growing at its full potential.
Dental Membrane and Bone Graft Substitutes Landscape: Competition Analysis
The dental membrane and bone graft substitutes market is moderately consolidated, with the top five companies accounting for ~55% of the market share, globally. These companies include Geistlich Pharma AG, Institut Straumann AG, Dentsply Sirona, Danaher Corporation, and Zimmer Biomet, who have, in recent years, focused on expanding their product offerings to include bio-based materials for implants, alveolar ridge reconstruction, localized ridge augmentation, and more. For instance, in February 2019, Zimmer Biomet announced the launch of OsseoGuard non-resorbable dental membranes and sutures, expanding its already considerable product portfolio.
Players in the dental membrane and bone graft substitutes landscape are also increasingly focusing on strengthening their presence, globally, by improving their distribution across regions as well. In May 2018, Dentsply Sirona, entered into a distribution collaboration agreement with Datum Dental, Ltd for the distribution of the Ossix product line, enabling the firm to expand its customer base in North America.
Expanding operations in future? To get the perfect launch ask for a custom report
More Trending Reports by Transparency Market Research – https://www.biospace.com/article/psoriasis-treatment-market-predictive-biomarkers-offer-opportunities-in-specialised-medicine/
No comments:
Post a Comment